We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
Read MoreHide Full Article
Universal Health Services, Inc.’s (UHS - Free Report) shares have gained 23.1% in the past three months compared with the industry’s 16.1% growth. It has also outperformed the broader Zacks Medical sector’s 4.9% rise and the S&P 500 Index’s 2.4% increase in the said time frame. The company has been benefiting on the back of strength in Acute Care Hospital Services and Behavioral Health Care Services segments coupled with a diversified treatment network and solid cash flows. It has a market cap of $15.7 billion.
Closing at $234.69 in the last trading session, the stock is just 3% below its 52-week high. Nevertheless, it is trading above its 50-day and 200-day moving averages, indicating solid upward momentum.
3-Month Price Performance
Image Source: Zacks Investment Research
Growth Drivers for UHS
Universal Health's revenues continue to benefit on the back of increased patient volumes in its Acute Care Hospital Services segment and improved patient days in the Behavioral Health Care Services unit. Admissions in its acute care hospitals advanced 3.9% year over year in the first half of 2024 while patient days in the behavioral health care facilities grew 2.1% year over year. Management estimates net revenues to be between $15.565 billion and $15.753 billion for 2024, the mid-point of which implies 9.6% growth from the 2023 figure.
The ongoing resumption of elective procedures deferred during the pandemic is expected to further elevate patient volumes and occupancy rates of healthcare facilities in the days ahead. As patient volumes are a crucial revenue driver for healthcare facility operators, this trend bodes well for Universal Health. Similarly, other such operators, such as HCA Healthcare, Inc. (HCA - Free Report) and Tenet Healthcare Corporation (THC - Free Report) , are also likely to reap the benefits of the abovementioned resumption.
Universal Health managed a comprehensive network of 359 inpatient and 48 outpatient facilities across 39 states, Washington D.C., the United Kingdom and Puerto Rico as of June 30, 2024. The rising prevalence of mental health conditions in the United States is anticipated to sustain the strong demand for the company’s behavioral health services, provided through its 332 inpatient behavioral healthcare facilities.
To bolster its market position, Universal Health focuses on introducing new services, enhancing existing ones, recruiting top-tier physicians and applying stringent financial and operational controls. These efforts enhance hospital profitability and service quality. Acquisitions are also part of the company’s strategy to enter new markets and enhance healthcare delivery.
Maintaining a robust financial base is crucial for supporting growth initiatives, a criterion that Universal Health meets with its strong cash reserves and cash-generating abilities. As of June 30, 2024, its cash and cash equivalents were up 7.8% from the 2023-end level. It generated $1.1 billion in operating cash flows in the first half of 2024, up 64.6% year over year . This cash-generating ability supports strategic investments and enables ongoing shareholder returns through regular dividends and share buybacks. Universal Health has maintained a steady dividend of 20 cents per share since 2019.
Estimate Revisions Favor Universal Health
Reflecting the positive sentiment around UHS, the Zacks Consensus Estimate for earnings per share has seen upward revisions. The consensus mark for 2024 earnings indicates a 51% year-over-year improvement while the estimate for 2025 earnings implies an increase of 9.7%. It beat earnings estimates in each of the last four quarters, with the average surprise being 14.58%. Moreover, the consensus mark for 2024 and 2025 revenues indicates 9.8% and 5.5% year-over-year growth, respectively.
Image Source: Zacks Investment Research
Challenges for UHS’ Business
Universal Health is grappling with elevated operating costs, which increased 7.3% year over year in the first half of 2024 due to the higher salaries, wages and benefits, other operating expenses and supplies costs. The rising costs will pressurize margins in the days ahead. Moreover, the company's debt-laden balance sheet induces an increase in interest expenses. Interest expenses rose 2% year over year in the first half of 2024.
UHS’ Favorable Valuation
Universal Health is trading at a discount compared with the industry average. It presents a compelling investment opportunity with its attractive forward 12-month price-to-earnings ratio of 13.79X, lower than the industry average of 16.22X.
Image Source: Zacks Investment Research
Conclusion: Apt to Buy UHS Stock Now
Universal Health is experiencing significant revenue growth, driven by strength across its two segments, coupled with the resumption of elective procedures. It is well-positioned to benefit from increased healthcare demands through its extensive network of facilities and strategic expansions. Although challenges such as escalating operating costs and a high debt burden exist, Universal Health’s cash-generating ability and strategic initiatives underscore its potential for sustained growth, providing a compelling opportunity for investors to add the stock to their portfolio. Its improving profit estimates and favorable valuation inspire investor optimism.
Image: Bigstock
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
Universal Health Services, Inc.’s (UHS - Free Report) shares have gained 23.1% in the past three months compared with the industry’s 16.1% growth. It has also outperformed the broader Zacks Medical sector’s 4.9% rise and the S&P 500 Index’s 2.4% increase in the said time frame. The company has been benefiting on the back of strength in Acute Care Hospital Services and Behavioral Health Care Services segments coupled with a diversified treatment network and solid cash flows. It has a market cap of $15.7 billion.
Closing at $234.69 in the last trading session, the stock is just 3% below its 52-week high. Nevertheless, it is trading above its 50-day and 200-day moving averages, indicating solid upward momentum.
3-Month Price Performance
Image Source: Zacks Investment Research
Growth Drivers for UHS
Universal Health's revenues continue to benefit on the back of increased patient volumes in its Acute Care Hospital Services segment and improved patient days in the Behavioral Health Care Services unit. Admissions in its acute care hospitals advanced 3.9% year over year in the first half of 2024 while patient days in the behavioral health care facilities grew 2.1% year over year. Management estimates net revenues to be between $15.565 billion and $15.753 billion for 2024, the mid-point of which implies 9.6% growth from the 2023 figure.
The ongoing resumption of elective procedures deferred during the pandemic is expected to further elevate patient volumes and occupancy rates of healthcare facilities in the days ahead. As patient volumes are a crucial revenue driver for healthcare facility operators, this trend bodes well for Universal Health. Similarly, other such operators, such as HCA Healthcare, Inc. (HCA - Free Report) and Tenet Healthcare Corporation (THC - Free Report) , are also likely to reap the benefits of the abovementioned resumption.
Universal Health managed a comprehensive network of 359 inpatient and 48 outpatient facilities across 39 states, Washington D.C., the United Kingdom and Puerto Rico as of June 30, 2024. The rising prevalence of mental health conditions in the United States is anticipated to sustain the strong demand for the company’s behavioral health services, provided through its 332 inpatient behavioral healthcare facilities.
To bolster its market position, Universal Health focuses on introducing new services, enhancing existing ones, recruiting top-tier physicians and applying stringent financial and operational controls. These efforts enhance hospital profitability and service quality. Acquisitions are also part of the company’s strategy to enter new markets and enhance healthcare delivery.
Maintaining a robust financial base is crucial for supporting growth initiatives, a criterion that Universal Health meets with its strong cash reserves and cash-generating abilities. As of June 30, 2024, its cash and cash equivalents were up 7.8% from the 2023-end level. It generated $1.1 billion in operating cash flows in the first half of 2024, up 64.6% year over year . This cash-generating ability supports strategic investments and enables ongoing shareholder returns through regular dividends and share buybacks. Universal Health has maintained a steady dividend of 20 cents per share since 2019.
Estimate Revisions Favor Universal Health
Reflecting the positive sentiment around UHS, the Zacks Consensus Estimate for earnings per share has seen upward revisions. The consensus mark for 2024 earnings indicates a 51% year-over-year improvement while the estimate for 2025 earnings implies an increase of 9.7%. It beat earnings estimates in each of the last four quarters, with the average surprise being 14.58%. Moreover, the consensus mark for 2024 and 2025 revenues indicates 9.8% and 5.5% year-over-year growth, respectively.
Image Source: Zacks Investment Research
Challenges for UHS’ Business
Universal Health is grappling with elevated operating costs, which increased 7.3% year over year in the first half of 2024 due to the higher salaries, wages and benefits, other operating expenses and supplies costs. The rising costs will pressurize margins in the days ahead. Moreover, the company's debt-laden balance sheet induces an increase in interest expenses. Interest expenses rose 2% year over year in the first half of 2024.
UHS’ Favorable Valuation
Universal Health is trading at a discount compared with the industry average. It presents a compelling investment opportunity with its attractive forward 12-month price-to-earnings ratio of 13.79X, lower than the industry average of 16.22X.
Image Source: Zacks Investment Research
Conclusion: Apt to Buy UHS Stock Now
Universal Health is experiencing significant revenue growth, driven by strength across its two segments, coupled with the resumption of elective procedures. It is well-positioned to benefit from increased healthcare demands through its extensive network of facilities and strategic expansions. Although challenges such as escalating operating costs and a high debt burden exist, Universal Health’s cash-generating ability and strategic initiatives underscore its potential for sustained growth, providing a compelling opportunity for investors to add the stock to their portfolio. Its improving profit estimates and favorable valuation inspire investor optimism.
UHS currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.